Veterinary Cardiology

Global Veterinary Cardiology Market to Reach US$4.2 Billion by 2030

The global market for Veterinary Cardiology estimated at US$2.7 Billion in the year 2024, is expected to reach US$4.2 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Companion Animals, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Production Animals segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$737.4 Million While China is Forecast to Grow at 11.9% CAGR

The Veterinary Cardiology market in the U.S. is estimated at US$737.4 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$893.6 Million by the year 2030 trailing a CAGR of 11.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Veterinary Cardiology Market – Key Trends & Drivers Summarized

Why Is Veterinary Cardiology Becoming a Pillar of Companion Animal Healthcare?

Veterinary cardiology is emerging as a crucial specialty in animal healthcare, driven by the increasing prevalence of heart-related conditions in companion animals and rising awareness among pet owners about the importance of early diagnosis and ongoing cardiac care. As pets live longer due to better nutrition, preventive care, and advanced medical treatments, age-related cardiovascular diseases—including congestive heart failure, arrhythmias, valve disorders, and congenital anomalies—are becoming more common. Dog breeds such as Cavalier King Charles Spaniels, Boxers, and Doberman Pinschers, as well as certain cat breeds, are genetically predisposed to heart issues, necessitating specialized care. Veterinary cardiologists and general practitioners alike are seeing a growing caseload of animals requiring diagnostics like echocardiography, electrocardiograms (ECGs), radiographic imaging, and cardiac biomarker testing. Pet owners, increasingly viewing their animals as family members, are more willing to pursue advanced diagnostic and therapeutic interventions to improve quality of life and extend longevity. This growing emphasis on animal wellness and specialized care is significantly expanding the demand for veterinary cardiology services across urban clinics, specialty hospitals, and academic veterinary centers worldwide.

How Are Innovations in Diagnostics and Imaging Enhancing Cardiac Care for Animals?

Technological innovation is reshaping veterinary cardiology, enabling earlier detection, more accurate diagnosis, and better monitoring of cardiovascular diseases in animals. Modern echocardiography machines now offer high-resolution, Doppler-based imaging tailored for veterinary use, allowing clinicians to assess blood flow, valve function, and chamber dimensions with high precision. Portable and wireless ECG systems are making it easier to perform heart rhythm analysis in clinical or even home-based settings, improving access to diagnostics in general practices and mobile services. Cardiac biomarkers such as NT-proBNP and troponin are being increasingly utilized for screening, staging, and monitoring heart disease, providing a minimally invasive complement to imaging diagnostics. Advanced imaging tools like 3D echocardiography, computed tomography (CT), and magnetic resonance imaging (MRI) are becoming more prevalent in veterinary referral centers, especially for complex cases. Telemedicine is also playing a growing role in veterinary cardiology, enabling practitioners to consult with specialists remotely and receive rapid interpretations of ECGs or echo results. These technological developments are streamlining workflows, enhancing clinical accuracy, and ultimately contributing to more effective management and improved outcomes in veterinary cardiac patients.

Why Are Veterinary Clinics and Specialty Hospitals Expanding Cardiology Services?

Veterinary clinics, specialty hospitals, and academic centers are increasingly investing in cardiology services to meet rising demand for specialized care and to offer full-service, integrated treatment for complex cases. General veterinary practices are incorporating basic cardiac screening tools—such as auscultation training, handheld ultrasound devices, and ECGs—into wellness exams and pre-anesthetic screenings, helping to catch early signs of cardiac disease. Referral and specialty hospitals are going a step further, establishing dedicated cardiology departments with board-certified specialists and state-of-the-art diagnostic suites. These centers are not only diagnosing but also managing chronic cardiac conditions with long-term pharmacologic therapy, pacemaker implantation, fluid management protocols, and surgical interventions when needed. Academic veterinary schools are strengthening cardiology curricula and expanding research in comparative cardiology, drug development, and congenital heart defect repair. Additionally, collaboration with pharmaceutical and medical device companies is leading to the development of new treatment options tailored for small animals. Clinics offering advanced cardiac care are gaining a competitive edge by addressing a growing segment of pet healthcare that is deeply valued by pet owners and often requires repeat visits, ongoing monitoring, and personalized treatment plans—resulting in stronger client relationships and higher lifetime patient value.

What’s Driving the Global Growth of the Veterinary Cardiology Market?

The growth in the veterinary cardiology market is driven by several interrelated factors tied to pet demographics, technological progress, clinical innovation, and increasing consumer willingness to invest in advanced animal care. A significant driver is the global rise in pet ownership and the growing trend of pet humanization, which has led to greater awareness of chronic and age-related conditions like heart disease. The availability of more accurate and affordable diagnostic tools is empowering general practitioners to screen and refer patients for specialized cardiac evaluations earlier in the disease cycle. Advancements in veterinary pharmaceuticals—especially in areas like ACE inhibitors, beta blockers, diuretics, and novel heart medications—are enabling more effective long-term management of cardiac conditions. The expansion of specialty care facilities and veterinary cardiology training programs is helping to bridge the gap in specialist access, particularly in urban centers. Furthermore, the growth of pet insurance coverage is making advanced cardiac care financially accessible to a larger client base. Research collaborations and clinical trials are also accelerating drug development and treatment protocols. Together, these factors are propelling veterinary cardiology from a niche specialty to a mainstream component of comprehensive pet healthcare, with growing influence on how clinics are structured, how veterinary professionals are trained, and how pet health is managed in the years to come.

SCOPE OF STUDY:

The report analyzes the Veterinary Cardiology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Animal Type (Companion Animals, Production Animals); Product (Pharmaceuticals, Diagnostics); Indication (Congestive Heart Failure, Myocardial Disease, Arrhythmias, Others); End-Use (Veterinary Hospitals & Clinics, Others)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• ALBA Medical Systems, Inc.
• Antech Diagnostics
• Boehringer Ingelheim International
• Bionet America
• Ceva Santé Animale
• Cronus Pharma
• Dextronix
• Esaote SpA
• FUJIFILM Holdings Corporation
• General Electric Company
• IDEXX Laboratories
• IMV Technologies
• Infiniti Medical
• Jurox
• Medtronic
• Merck & Co., Inc.
• Patterson Veterinary
• Pet Cardiology
• RHC Medical
• Scapa Healthcare

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.